Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Pegasus Mercantile Inc. R (U040.F)

Compare
0.0775
0.0000
(0.00%)
At close: 8:11:01 AM GMT+2
Loading Chart for U040.F
  • Previous Close 0.0775
  • Open 0.0775
  • Bid 0.0645 x --
  • Ask 0.1290 x --
  • Day's Range 0.0775 - 0.0775
  • 52 Week Range 0.0134 - 0.1850
  • Volume 3
  • Avg. Volume 223
  • Market Cap (intraday) 1.352M
  • Beta (5Y Monthly) -0.59
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pegasus Mercantile Inc. is an incubator, venture capital and accelerator firm specializing in incubation and startup. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet. The firm seeks to invest in Canada. The firm also provides debt financing facility. Pegasus Mercantile Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada with an additional office in Vancouver, Canada.

xtacytherapeutics.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: U040.F

View More

Performance Overview: U040.F

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

U040.F
6.06%
S&P/TSX Composite index (^GSPTSE)
1.68%

1-Year Return

U040.F
3.12%
S&P/TSX Composite index (^GSPTSE)
12.84%

3-Year Return

U040.F
90.00%
S&P/TSX Composite index (^GSPTSE)
14.03%

5-Year Return

U040.F
79.61%
S&P/TSX Composite index (^GSPTSE)
94.41%

Compare To: U040.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: U040.F

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    1.35M

  • Enterprise Value

    1.36M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    22.76

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    36.57

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -58.25%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -195.68k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -945.93k

Research Analysis: U040.F

View More

Company Insights: U040.F

Research Reports: U040.F

View More

People Also Watch